ESC 365 - A collaborative working project in primary care: optimising lipid lowering therapies for secondary prevention in high risk patients

Delegates Premium Access

A collaborative working project in primary care: optimising lipid lowering therapies for secondary prevention in high risk patients

Session: Dyslipidaemia management in 2025: status quo and best practice (1)

Topic: Lipids

Speaker: Doctor J. Ward (Westbury, GB)

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Doctor John Ward

Westbury Group Practice, Westbury (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Does the length of evolocumab use contribute to myocardial infarction associated hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE

Speaker: Doctor O. Wani (Flagstaff, US)

Statin intolerance in a real word setting of Italian cardiology centers: data from the BRING-UP Prevention study

Speaker: Doctor S. Di Fusco (Rome, IT)

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore

Speaker: Doctor W. Loh (Singapore, SG)

The prevalence and accumulation of main cardiometabolic risk factors among the finnish adult population at different levels of lp(a)

Speaker: Professor P. Jousilahti (Helsinki, FI)

Access the full session

Dyslipidaemia management in 2025: status quo and best practice (1)

Speakers: Doctor J. Ward, Doctor O. Wani, Doctor S. Di Fusco, Doctor W. Loh, Professor P. Jousilahti

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources